The deadly impact of extreme drug resistance in Acinetobacter baumannii

Affiliations

¹ Division of General Internal Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA; and, Division of General Internal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA Department of Medicine, Department of Pharmacology; and, Department of Molecular Biology and Microbiology, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, OH.

Editorial

Brad Spellberg et al. Crit Care Med. 2014 May.

. 2014 May;42(5):1289-91.

doi: 10.1097/CCM.0000000000000181.

¹ Division of General Internal Medicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA; and, Division of General Internal Medicine, David Geffen School of Medicine at UCLA, Los Angeles, CA Department of Medicine, Department of Pharmacology; and, Department of Molecular Biology and Microbiology, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Case Western Reserve University, Cleveland, OH.

No abstract available

Comment on

Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients.
Lee HY, Chen CL, Wu SR, Huang CW, Chiu CH. Lee HY, et al. Crit Care Med. 2014 May;42(5):1081-8. doi: 10.1097/CCM.0000000000000125. Crit Care Med. 2014. PMID: 24394630

1. Glew RH, Moellering RC, Jr, Kunz LJ. Infections with Acinetobacter calcoaceticus (Herellea vaginicola): Clinical and laboratory studies. Medicine (Baltimore) 1977;56:79–97. - PubMed
1. Seifert H, Strate A, Pulverer G. Nosocomial bacteremia due to Acinetobacter baumannii Clinical features, epidemiology, and predictors of mortality. Medicine (Baltimore) 1995;74:340–349. - PubMed
1. Tilley PA, Roberts FJ. Bacteremia with Acinetobacter species: Risk factors and prognosis in different clinical settings. Clin Infect Dis. 1994;18:896–900. - PubMed
1. Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 2005;11:868–873. - PubMed
1. Melsen WG, Rovers MM, Groenwold RH, et al. Attributable mortality of ventilator-associated pneumonia: A meta-analysis of individual patient data from randomised prevention studies. Lancet Infect Dis. 2013;13:665–671. - PubMed